Healthy adult
Conditions
Interventions
Oral ingestion of oligosaccharide for 2 weeks.
Sponsors
Meiji Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Those who provided specimens in which oligosaccharide increased the number of useful bacteria in vitro 2. Those who belongs to R&D division on the date of consent 3. Those who have received sufficient explanation about the purpose and content of this study, have the ability to consent, fully volunteered with voluntary intention, agreed to participate
Exclusion criteria
Exclusion criteria: 1. Those who have participated in a study involving another intervention during the month prior to screening or who plan to participate in a study involving another intervention during the period between screening and the end of the intake period 2. Those who have a history of gastric or lower gastrointestinal tract surgery excluding hemorrhoids 3. Those who have a barium stomach X-ray, small or large intestine endoscopy, or bowel cleansing at a clinic or at home during the month prior to screening, or those who are scheduled to have these procedures during this study 4. Who have taken, ingested, or used drugs that may affect the study at least once a week during the month prior to screening, or who plan to take, ingest, or use these drugs at least once during the study 5. Those who plan to travel abroad, travel for more than one week, or go on a business trip during the period from one week prior to the intake period to the end of the intake period 6. Subjects judged as unsuitable for the study by the principal investigator or research physician for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gut microbiota | — |
Countries
Japan
Contacts
Public ContactSeiya Makino
Meiji Co., Ltd. R&D Division
Outcome results
None listed